Celastrol attenuates hypertension-induced inflammation and oxidative stress in vascular smooth muscle cells via induction of heme oxygenase-1.
about
Celastrol, an NF-κB inhibitor, improves insulin resistance and attenuates renal injury in db/db miceQuantitative proteomics reveals cellular targets of celastrolCelastrol prevents atherosclerosis via inhibiting LOX-1 and oxidative stressCelastrol inhibits lung infiltration in differential syndrome animal models by reducing TNF-α and ICAM-1 levels while preserving differentiation in ATRA-induced acute promyelocytic leukemia cellsCelastrol prevents cadmium-induced neuronal cell death via targeting JNK and PTEN-Akt/mTOR network.Celastrol, an oral heat shock activator, ameliorates multiple animal disease models of cell death.Celastrol protects ischaemic myocardium through a heat shock response with up-regulation of haeme oxygenase-1.Celastrol inhibits proliferation and induces chemosensitization through down-regulation of NF-κB and STAT3 regulated gene products in multiple myeloma cells.Proteostasis and REDOX state in the heart.Celastrol ameliorates Cd-induced neuronal apoptosis by targeting NOX2-derived ROS-dependent PP5-JNK signaling pathway.Celastrol induces apoptosis and autophagy via the ROS/JNK signaling pathway in human osteosarcoma cells: an in vitro and in vivo study.Celastrol attenuates oxidative stress in the skeletal muscle of diabetic rats by regulating the AMPK-PGC1α-SIRT3 signaling pathway.Tripterygium wilfordii bioactive compounds as anticancer and anti-inflammatory agents.Terpenoids: natural products for cancer therapy.Heme Oxygenases in Cardiovascular Health and Disease.Celastrol protects TGF-β1-induced endothelial-mesenchymal transition.Celastrol Protects against Antimycin A-Induced Insulin Resistance in Human Skeletal Muscle Cells.Celastrol: A Spectrum of Treatment Opportunities in Chronic DiseasesCelastrol ameliorates inflammation through inhibition of NLRP3 inflammasome activation.Effects of cryptotanshinone on the expression levels of inflammatory factors in myocardial cells caused by Ang II and its mechanism.Celastrol specifically inhibits the activation of NLRP3 inflammasome.
P2860
Q27323293-F24DB5BC-57CE-4E25-A3BC-C035AFA8A1ECQ28477634-B3724F7D-B473-4B15-99DD-413C59F7264DQ28533974-36433E64-C77F-4F25-B7C9-997B235CDA27Q28541829-0D78DFDF-D72D-4869-89F1-56FE06E129E7Q34280571-CC7CEC43-9D3F-4962-8D77-813D839D7098Q34628984-DE83612D-85E8-44CD-87B3-614209BF638CQ34953350-88D33FD7-4AE4-4C72-ACF6-F6BE8E94FD05Q35564293-E1A47FD4-D23D-4CF9-AC05-E3FC15798525Q35906430-4D066897-923A-4FAE-890B-5BDB83058897Q36262736-0F6783BF-68E6-45B7-894C-554A67D86B2BQ36347072-38A3623A-8F42-4440-BC32-D9C418D5D087Q36791238-980732C3-211A-4D87-A78E-EFCFF6DD53C6Q37915623-5E49F440-E0D3-4A7C-9CDB-CC71B6EA0106Q38054798-75B73134-3A94-49BE-951E-EE4965812CD4Q38823562-1828DC03-62EC-4798-A1EB-27CF5E6A4680Q38843301-61BA16B9-1845-46F2-A899-798982E5EC6AQ38876792-99ED0D0E-D72E-4285-AEA0-D1D2379D6BABQ39406168-56FAA179-960A-4E59-8A54-AC55D8BD376CQ42366543-46A1FAB2-1AFD-4208-AD91-F0A244C54C21Q43210206-1367D73A-64BE-4D71-A532-284CA25EA913Q47700597-E70FA213-5083-4E78-9450-66B924E1C118
P2860
Celastrol attenuates hypertension-induced inflammation and oxidative stress in vascular smooth muscle cells via induction of heme oxygenase-1.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Celastrol attenuates hypertens ...... induction of heme oxygenase-1.
@en
Celastrol attenuates hypertens ...... induction of heme oxygenase-1.
@nl
type
label
Celastrol attenuates hypertens ...... induction of heme oxygenase-1.
@en
Celastrol attenuates hypertens ...... induction of heme oxygenase-1.
@nl
prefLabel
Celastrol attenuates hypertens ...... induction of heme oxygenase-1.
@en
Celastrol attenuates hypertens ...... induction of heme oxygenase-1.
@nl
P2093
P2860
P356
P1476
Celastrol attenuates hypertens ...... induction of heme oxygenase-1.
@en
P2093
Chaojun Li
Fengrong Jiang
Jiandie Lin
Weiwei Tao
P2860
P304
P356
10.1038/AJH.2010.75
P577
2010-04-22T00:00:00Z